Zurück zur Trefferliste

Haedicke / Stief / Bühler

Pharmaceutical, Biological and Chemical Patents

Praxisnah und umfassend.
2019. Buch. Rund 2000 S. Hardcover (In Leinen)
C.H.BECK ISBN 978-3-406-64855-7
Format (B x L): 16,0 x 24,0 cm
(In Gemeinschaft mit Hart Publishing, Oxford und Nomos Verlagsgesellschaft, Baden-Baden)
Das Werk ist Teil der Reihe:
The topic of pharmaceutical, biological and chemical patents is a special matter within European and German patent law. There are several structural alterations, like polymorphism and enantiomerism, leading to a derivative of a substance that is comprised in the prior art. This gives rise to the question under what circumstances such alterations can be novel and in which cases they are included in the state of the art. But even if a substance is prior art, a new medical use of it can be patented, as such medical use patents are politically intended to promote medical research.

On the other hand, it is unclear how to deal with natural occurrences of a substance in terms of its accessibility and bioethics.

It must also be understood how different identifications of a substance and the resulting patents interrelate with each other, i.e. how their scopes of protection are defined. This is problematic especially because of the absolute substance protection, which includes all conceivable uses and methods.

The past decisions of the ECJ as regards broccoli- and tomato-patents, as well as embryonic stem cells have high-lighted the importance of this field of law.

Most of the proceedings regarding pharmaceutical, biological and chemical patents are held in German courts. The German jurisprudence is also of importance to the subject matter, as it has often been the basis for decisions of the ECJ. Thus, German case law is used to illustrate the comments.

vorbestellbar, wir liefern bei Erscheinen

Erscheint vsl. Oktober 2019

ca. 320,00 €
inkl. MwSt.
Bereits u.d.T. "Chemical and Biological Patents"
By link iconProf. Dr. Maximilian W. Haedicke, LL.M., Richter am Oberlandesgericht, link iconDr. Marco Stief, LL.M., Rechtsanwalt, and link iconDr. Dirk Bühler